Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates

Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Sasilada Sirirungruang, Yunlong Zhang, Delai Chen, Roman L. Bogorad, Hao Yin, Yi Chen, Arturo J. Vegas, Christopher A. Alabi, Gaurav Sahay, Karsten T. Olejnik, Weiheng Wang, Avi Schroeder, Abigail K. R. Lytton-Jean, Daniel J. Siegwart, Akin Akinc, Carmen Barnes, Scott A. Barros, Mary Carioto, Kevin Fitzgerald, Julia Hettinger, Varun Kumar, Tatiana I. Novobrantseva, June Qin, William Querbes, Victor Koteliansky, Robert Langer, and Daniel G. Anderson
PNAS first published February 10, 2014 https://doi.org/10.1073/pnas.1322937111

  1. Edited* by Alexander M. Klibanov, Massachusetts Institute of Technology, Cambridge, MA, and approved January 16, 2014 (received for review December 10, 2013)

This article has a correction. Please see:

See related content:

Significance

The safe, selective, and efficient delivery of siRNA is a key challenge to the broad application of siRNA therapeutics in humans. Motivated by the structure of lipoproteins, we developed lipopeptide nanomaterials for siRNA delivery. In vivo in mice, siRNA–lipopeptide particles provide the most potent delivery to hepatocytes (ED50 ∼ 0.002 mg/kg for FVII silencing), with the highest selectivity of delivery to hepatocytes over nontarget cell types (orders of magnitude), yet reported. These materials also show efficacy in nonhuman primates.

Abstract

siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date.

Footnotes

  • ↵1To whom correspondence should be addressed. E-mail: dgander{at}mit.edu.

  • Author contributions: Y.D., R.L., and D.G.A. designed research; Y.D., K.T.L., J.R.D., S.S., Y.Z., D.C., R.L.B., H.Y., Y.C., A.J.V., C.A.A., G.S., K.T.O., W.W., A.S., A.K.R.L.-J., A.A., C.B., S.A.B., M.C., K.F., J.H., V. Kumar, T.I.N., J.Q., W.Q., and V. Kotelianski performed research; Y.D., K.T.L., J.R.D., S.S., Y.Z., D.C., R.L.B., H.Y., Y.C., A.J.V., C.A.A., G.S., K.T.O., W.W., A.S., A.K.R.L.-J., A.A., C.B., S.A.B., M.C., K.F., J.H., V. Kumar, T.I.N., J.Q., W.Q., V. Kotelianski, R.L., and D.G.A. analyzed data; and Y.D., K.T.L., A.J.V., C.A.A., D.J.S., R.L., and D.G.A. wrote the paper.

  • Conflict of interest statement: R.L. is a shareholder and member of the Scientific Advisory Board of Alnylam. D.G.A. is a consultant with Alnylam. R.L and D.G.A have sponsored research grants from Alnylam. Alnylam also has a license to certain intellectual property invented at Massachusetts Institute of Technology. A.A., S.A.B., M.C., K.F., J.H., V. Kumar, J.Q., and W.Q. are employed by Alnylam.

  • ↵*This Direct Submission article had a prearranged editor.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1322937111/-/DCSupplemental.

Freely available online through the PNAS open access option.

Back to top
Article Alerts
Email Article
Citation Tools
Request Permissions
Lipopeptides and selective siRNA delivery
Yizhou Dong, Kevin T. Love, J. Robert Dorkin, Sasilada Sirirungruang, Yunlong Zhang, Delai Chen, Roman L. Bogorad, Hao Yin, Yi Chen, Arturo J. Vegas, Christopher A. Alabi, Gaurav Sahay, Karsten T. Olejnik, Weiheng Wang, Avi Schroeder, Abigail K. R. Lytton-Jean, Daniel J. Siegwart, Akin Akinc, Carmen Barnes, Scott A. Barros, Mary Carioto, Kevin Fitzgerald, Julia Hettinger, Varun Kumar, Tatiana I. Novobrantseva, June Qin, William Querbes, Victor Koteliansky, Robert Langer, Daniel G. Anderson
Proceedings of the National Academy of Sciences Feb 2014, 201322937; DOI: 10.1073/pnas.1322937111
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Proceedings of the National Academy of Sciences: 116 (38)
Current Issue

Submit

Jump to section

You May Also be Interested in

Habituation and training of the ravens in the experimental compartments, Haidlhof Research Station, Austria. Image courtesy of Jessie E. C. Adriaense.
Shared emotional states in ravens
Researchers report negative emotional contagion, or the coordination of emotional states between multiple individuals, in common ravens, suggesting convergent emotional evolution in birds and mammals.
Image courtesy of Jessie E. C. Adriaense.
Fishing fleet. Image courtesy of Pixabay/3282700.
Increase in global fishing fleets
A study examines trends in global fishing fleets and finds that by 2015, 68% of the global fishing fleet became motorized, and that the overall number of fleet vessels increased to 3.7 million, despite a consistent decrease in the catch per unit of effort.
Image courtesy of Pixabay/3282700.
Magnified views of fingerprints found on fragments of 11th-century AD jars from the U S Southwest enabled archaeologists to determine the sex of the potter. Image courtesy of John Kantner.
Fingerprints reveal gender roles in ancient society
A method to determine gender from fingerprints suggests pottery making was not a primarily female activity in ancient Puebloan society, challenging previous assumptions about gendered divisions of labor in ancient societies.
Image courtesy of John Kantner.

Similar Articles